List of works - Arrigo Schieppati

Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome

Assessment of renal pathology and dysfunction in children with Fabry disease.

scientific article published on 07 January 2010

BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic Syndrome

scientific article published on 24 February 2017

Cavour's death and the political difficulties of Italian medicine – Author's reply

scientific article published in The Lancet

Chronic renal diseases as a public health problem: epidemiology, social, and economic implications

article

Clinical practice. Nephropathy in patients with type 2 diabetes

scientific article

Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN)

scientific article published on 16 October 2009

Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries

scientific article

Conflict of interest as seen from a researcher's perspective

scientific article

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study ⬇️

scientific article published on September 2, 2012

Diseases of the Kidney and the Urinary System

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

scientific article published on 31 August 2014

Eliminating treatable deaths due to acute kidney injury in resource-poor settings

scientific article

Fighting Renal Diseases in Poor Countries: Building a Global Fund with the Help of the Pharmaceutical Industry

scientific article published on 01 March 2004

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

scientific article published on 28 February 2013

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

scientific article (publication date: 16 October 2014)

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

scientific article

Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review

article

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review

scientific article published in September 2004

Independent clinical research in Europe.

scientific article published in November 2004

Inhibition of Human Platelet Aggregation by Parathyroid Hormone

Kidney failure: aims for the next 10 years and barriers to success

scientific article published on 31 May 2013

Kidney prevention recipes for your office practice

scientific article

Low mortality and key aspects of delivery of care for end-stage renal disease in Italy.

scientific article published on 21 May 2009

Lupus Nephritis

Nonimmunosuppressive therapy of membranous nephropathy

Novel therapies of lupus nephritis

scientific article published on March 2008

Orphan drugs - Authors' reply

scientific article published on 01 April 2019

Outrageous prices of orphan drugs: a call for collaboration

scientific article published on 20 July 2018

Pathophysiology of disease progression in proteinuric nephropathies

scientific article

Pharmacotherapy options for membranous nephropathy

Prevalence and significance of hypertension in systemic lupus erythematosus

scholarly article by Arrigo Schieppati et al published May 1993 in American Journal of Kidney Diseases

Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries

scientific article

Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries

scientific article published on 01 May 2003

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration

scientific article published on September 2005

Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?

scientific article

Prevention programmes of progressive renal disease in developing nations

scientific article published on August 2006

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

Prognosis of untreated patients with idiopathic membranous nephropathy

Rare autoimmune diseases

scientific article published on January 1, 2010

Rare diseases and effective treatments: are we delivering?

scientific article

Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.

scientific article published on 2 April 2016

Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.

scientific article published on 2 April 2016

Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.

scientific article published on 8 April 2016

Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe

scientific article published on 23 April 2016

Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe.

scientific article

Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.

scientific article published on 4 April 2016

Social/economic costs and health-related quality of life in patients with scleroderma in Europe.

scientific article published on 2 April 2016

Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.

scientific article published on 9 April 2016

Social/economic costs and quality of life in patients with haemophilia in Europe.

scientific article

Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia

scientific article

Tackling the Problem of Rare Diseases in Public Health: The Italian Approach

article

Tacrolimus and ciclosporin microemulsion in renal transplantation

scientific article

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises

scientific article published in December 2003

The future of renoprotection

scientific article

The scientific care for prevention: an overview

scientific article

The social burden and quality of life of patients with haemophilia in Italy

scientific article

The uses of error: diagnostic preferences

scientific article published in The Lancet

Treatment of Anemia and Bleeding in Chronic Kidney Disease

article

Treatment of idiopathic membranous glomerulopathy

scientific article published on March 1994

Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries

scientific article published on 27 March 2012

Why rare diseases are an important medical and social issue

scientific article published on June 2008

Why rare diseases?

scientific article published on January 2011

[Drugs for rare diseases: the blessing of being orphans.]

scientific article published on 01 May 2019

List of works by Arrigo Schieppati

Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome

Assessment of renal pathology and dysfunction in children with Fabry disease.

BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic Syndrome

Cavour's death and the political difficulties of Italian medicine – Author's reply

Chronic renal diseases as a public health problem: epidemiology, social, and economic implications

Clinical practice. Nephropathy in patients with type 2 diabetes

Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN)

Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries

Conflict of interest as seen from a researcher's perspective

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study ⬇️

Diseases of the Kidney and the Urinary System

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

Eliminating treatable deaths due to acute kidney injury in resource-poor settings

Fighting Renal Diseases in Poor Countries: Building a Global Fund with the Help of the Pharmaceutical Industry

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review

Independent clinical research in Europe.

Inhibition of Human Platelet Aggregation by Parathyroid Hormone

Kidney failure: aims for the next 10 years and barriers to success

Kidney prevention recipes for your office practice

Low mortality and key aspects of delivery of care for end-stage renal disease in Italy.

Lupus Nephritis

Nonimmunosuppressive therapy of membranous nephropathy

Novel therapies of lupus nephritis

Orphan drugs - Authors' reply

Outrageous prices of orphan drugs: a call for collaboration

Pathophysiology of disease progression in proteinuric nephropathies

Pharmacotherapy options for membranous nephropathy

Prevalence and significance of hypertension in systemic lupus erythematosus

Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries

Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration

Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?

Prevention programmes of progressive renal disease in developing nations

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

Prognosis of untreated patients with idiopathic membranous nephropathy

Rare autoimmune diseases

Rare diseases and effective treatments: are we delivering?

Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.

Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.

Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.

Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe

Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe.

Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.

Social/economic costs and health-related quality of life in patients with scleroderma in Europe.

Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.

Social/economic costs and quality of life in patients with haemophilia in Europe.

Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia

Tackling the Problem of Rare Diseases in Public Health: The Italian Approach

Tacrolimus and ciclosporin microemulsion in renal transplantation

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises

The future of renoprotection

The scientific care for prevention: an overview

The social burden and quality of life of patients with haemophilia in Italy

The uses of error: diagnostic preferences

Treatment of Anemia and Bleeding in Chronic Kidney Disease

Treatment of idiopathic membranous glomerulopathy

Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries

Why rare diseases are an important medical and social issue

Why rare diseases?

[Drugs for rare diseases: the blessing of being orphans.]